IVD Test Reagent/Kits, Molecular Assay, Infection, Bacteria, Mycobacterium tuberculosis

Definition : Molecular assay reagents intended to identify Mycobacterium tuberculosis, a species of slow-growing bacterium of the genus Mycobacterium, family Mycobacteriaceae, by detecting specific genetic information of the nucleic acid of the target bacteria. These bacteria are the etiologic agent of human tuberculosis.

Entry Terms : "Tuberculosis Diagnostic Reagents" , "Tuberculosis Mycobacteria Detection/Identification Reagents" , "Mycobacteria tuberculosis Identification Reagents" , "Mycobacteria tuberculosis Reagents, Identification" , "Mycobacterium tuberculosis Detection/Identification Reagents" , "Mycobacterium Reagents, Identification" , "Mycobacterium Species Detection/Identification Reagents" , "Reagents, Molecular Assay, Infection, Bacteria, Mycobacterium tuberculosis"

UMDC code : 19564

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-5 of 5 Match(es).

Alere Inc

Company Type: Parent

Alere Inc., a global healthcare company, announced a new partnership with Population Services International as part of the "Make (+) Positive More Positive Campaign.

Calbiotech Inc

Company Type: Parent

Calbiotech specialty is in custom design of immunoassay products for human and animal applications.

InBios International Inc

Company Type: Parent

InBios International, Inc. is a medical diagnostic company that specializes in developing, manufacturing and marketing medical diagnostic tests for the detection of infectious diseases. Since its inception in 1996, InBios has developed proprietary technologies useful in the development of rapid and ELISA based immunodiagnostic assays. It has also licensed antigens from major corporations and research organizations from which a number of its assays have been developed.

Oxford Immunotec Inc

Company Type: Parent

ZeptoMetrix Corp

Company Type: Parent

ZeptoMetrix is a privately held company formed in 1999 to serve the diagnostic and pharmaceutical research products industries. In 2003, the company acquired the BioClinical Partners division of Impath Corporation and a highly complementary and successful partnership was formed.

1-5 of 5 Match(es).

 

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone